Emphysema Clinical Trial
Official title:
Effectiveness of Different Exercise Training Programs to the Profile of COPD Patients
Aims: To prove the benefits of an specific strength training program in COPD patients
compared to those achieved with the traditional endurance training. We will assess which is
the proper training modality and which of them is the most beneficial according to the
features of the patient to whom it is applied.
Subjects and Methods: We will study 66 patients diagnosed of COPD with a moderate-severe
obstruction (FEV1<60%) and clinically symptomatic. The monitoring will be done for 3 moths.
Patients will be differentiated between COPD with "predominant chronic bronchitis" and COPD
with "predominant emphysema", with regard to clinical, functional and radiological criteria.
After stratification of the sample, patients will be prospectively assigned to three groups
of 22 patients each: a) Endurance training group, on cycle ergometer at a workload of 70%
VO2max. b) Strength training group, with 5 different weightlifting exercises (4 sets of 6-8
repetitions). c) Mixed training group, with half the time dedicated to each type of
training. Training will be developed during 12 weeks, three times per week, in 40 minutes
sessions. Analysed variables, at the beginning and at the end of program will be: Chest
X-ray, basic blood analyses, electrocardiogram, simple spirometry and bronchodilator test,
blood gases, static pulmonary volumes, diffusion measurement and respiratory muscle
pressure. Muscle strength will be assessed by means of 1RM test and the Myometer®
dynamometer. Using the muscle skeletal ultrasound, we will control changes in muscle fibre
size. Maximal and submaximal exercise tests on cycle ergometer will be also performed, so as
a walking test (shuttle walking test). At last, we will assess treatment effect on dyspnea
(Mahler`s test) and quality of life (CRDQ).
Hypothesis: A strength training program would significantly increase peripheral muscle
power. This type of training would mainly have effect on the "predominant emphysema" COPD
patient, where the important weight lost causes a decrease in muscle strength.
Status | Completed |
Enrollment | 66 |
Est. completion date | December 2010 |
Est. primary completion date | December 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 45 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Patients with COPD diagnosed according to criteria established by the A.. TS (American Thoracic Society) and the SEPAR (Spanish Society of Pneumology and Thoracic Surgery) to submit a modereda-severe obstruction to airflow. (FEV1 <60%) and a clinical impact of their disease. Exclusion Criteria: - other cardiorespiratory diseases. - Systemic diseases - Inability or discomfort to participate in an exercise program |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitario Virgen del Rocio | Sevilla |
Lead Sponsor | Collaborator |
---|---|
Hospitales Universitarios Virgen del Rocío | Fondo de Investigacion Sanitaria |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Increase in minute submaximal exercise test | Check that exercise training increases the tolerance time of submaximal test | Parameters will be measured at baseline and end of follow-up period of 12 months | No |
Secondary | Meters increased 6-minute test after training exercise | Check that exercise training increases the distance stroll on the walking test | Parameters will be measured at baseline and end of follow-up period of 12 months | No |
Secondary | Kg increase in the 1RM test after training exercise | Increased peripheral muscle strength (1RM test) after training exercise | Parameters will be measured at baseline and end of follow-up period of 12 months | No |
Secondary | Improvement in dyspnea with a fall of one point in the BDI | better control of symptoms (BDI test) after exercise training | Parameters will be measured at baseline and end of follow-up period of 12 months | No |
Secondary | Improved quality of life (CRQ) of at least one point (clinically significant) after exercise training | better quality of life (CRQ) after exercise training | Parameters will be measured at baseline and end of follow-up period of 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05825261 -
Exploring Novel Biomarkers for Emphysema Detection
|
||
Completed |
NCT02999685 -
Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients
|
N/A | |
Completed |
NCT02914340 -
REACH SVS Control Patient Cross-Over Study
|
N/A | |
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Completed |
NCT02238327 -
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
|
||
Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01710449 -
Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen
|
Phase 1 | |
Suspended |
NCT00523094 -
Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure
|
N/A | |
Completed |
NCT00475007 -
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
|
N/A | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Completed |
NCT01953523 -
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
|
N/A | |
Completed |
NCT00000621 -
Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
|
Phase 2 | |
Completed |
NCT00005292 -
Alpha1-antitrypsin Deficiency Registry
|
N/A | |
Recruiting |
NCT04537182 -
Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema
|
N/A | |
Active, not recruiting |
NCT02713347 -
Advancing Symptom Alleviation With Palliative Treatment
|
N/A | |
Recruiting |
NCT04302272 -
STRIVE Post-Market Registry Study
|
||
Completed |
NCT04435327 -
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
|
||
Completed |
NCT03636347 -
A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.
|
Phase 2 |